Compare VCEL & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VCEL | SENS |
|---|---|---|
| Founded | 1989 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 308.5M |
| IPO Year | 1996 | 2014 |
| Metric | VCEL | SENS |
|---|---|---|
| Price | $30.61 | $6.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $58.50 | $22.70 |
| AVG Volume (30 Days) | ★ 631.7K | 517.4K |
| Earning Date | 05-07-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $276,259,000.00 | $16,389,000.00 |
| Revenue This Year | $19.10 | $70.20 |
| Revenue Next Year | $17.95 | $59.10 |
| P/E Ratio | $91.69 | ★ N/A |
| Revenue Growth | 16.45 | ★ 19.85 |
| 52 Week Low | $28.95 | $0.41 |
| 52 Week High | $45.97 | $8.75 |
| Indicator | VCEL | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 36.78 | 40.42 |
| Support Level | $29.59 | $5.41 |
| Resistance Level | $38.48 | $6.87 |
| Average True Range (ATR) | 1.54 | 0.39 |
| MACD | -0.17 | 0.05 |
| Stochastic Oscillator | 26.90 | 51.84 |
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.